A Study to Learn More About the Eye (Intraocular Pressure, Ocular Hemodynamics) After Intravitreal Injections

Overview

About this study

The purpose of this study is to find out how much the eye pressure increases after giving the injection, and what happens to the blood supply of the various parts of the eye.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Either gender.
Adult subjects, 18 years of age and older.
Any self-declared ethno-racial category.
Best-corrected visual acuity (BCVA) 20/50 or better in the eye to be injected.
Ability to cooperate for examinations required for study.
Advised to undergo intravitreal anti- VEGF injection for any indication such as age related macular degeneration and diabetic retinopathy

Exclusion Criteria:

Ophthalmic:

Cornea pathologic changes preventing reliable measurement.
Narrow anterior chamber angle.
Previous intraocular surgeries, laser procedures, and intravitreal injections.
Known hypersensitivity to topical anesthetic medication.

Systemic:

Participation in any interventional study within the past 30 days prior to study visit.
Women who are pregnant.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Arthur Sit, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Arthur Sit, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials